TXA-6101

N/A

Report date: 2022/08/12 14:21:13
NME

Base Information

Drug NameTXA-6101
Drug Alias NameTXA-6101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial FtsZ proteins inhibitors
TargetsBacterial FtsZ proteins
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTaxis Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesTaxis Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A